iBio (IBIO) Net Margin Growth (5y) (2016 - 2025)
iBio (IBIO) Net Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -381,659.00 |
| Jun 30, 2025 | -222,430.00 |
| Dec 31, 2024 | 590,303.00 |
| Jun 30, 2024 | -201,512.00 |
| Sep 30, 2023 | 857,600.00 |
| Mar 31, 2022 | 995,761.00 |
| Sep 30, 2021 | -398,735.00 |
| Jun 30, 2021 | 98,384.00 |
| Mar 31, 2021 | -20,875.00 |
| Dec 31, 2020 | 51,833.00 |
| Sep 30, 2020 | -72,154.00 |
| Jun 30, 2020 | 27,735.00 |
| Mar 31, 2020 | -449,040.00 |
| Dec 31, 2019 | -739,620.00 |
| Sep 30, 2019 | -400,585.00 |
| Jun 30, 2019 | -1,362.00 |
| Jun 30, 2018 | -470,887.00 |
| Sep 30, 2017 | -272,324.00 |
| Jun 30, 2017 | -237,305.00 |
| Mar 31, 2017 | -1.01 Mn |